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Vertebrates engage in symbiotic associations with vast and com-
plex microbial communities that colonize their gastrointestinal
tracts. Recent advances have provided mechanistic insight into the
important contributions of the gut microbiome to vertebrate
biology, but questions remain about the evolutionary processes
that have shaped symbiotic interactions in the gut and the con-
sequences that arise for both the microbes and the host. Here we
discuss the biological principles that underlie microbial symbiosis
in the vertebrate gut and the potential of the development of
mutualism. We then review phylogenetic and experimental stud-
ies on the vertebrate symbiont Lactobacillus reuteri that have pro-
vided novel insight into the ecological and evolutionary strategy
of a gut microbe and its relationship with the host. We argue that
a mechanistic understanding of the microbial symbiosis in the ver-
tebrate gut and its evolution will be important to determine how
this relationship can go awry, and it may reveal possibilities by
which the gut microbiome can be manipulated to support health.
vertebrate symbiont | microbiota | mutualism
Prokaryotic microorganisms arose more than 3 billion y agoand have diversified to occupy virtually all environments that
became available. Multicellular eukaryotes appeared later, and
their bodies provided new habitats for microbial exploitation.
The microbial communities that inhabit the digestive tracts of
vertebrates are especially impressive both in sheer number and
complexity. The largest populations are found in the digestive
tracts of mammals, which can contain 1010 to 1012 cells/mL (e.g.,
in the rumen and large intestines), the highest cell numbers
recorded for any known microbial ecosystem (1). These com-
munities are comprised of thousands of species, and their di-
versity and metabolic capacity is specific for a particular host
animal and gut segment. Technical advances in the molecular
characterization of the gut microbiota and work with animal
models have begun to provide insight into the diversity of these
communities and their interactions with the host (2–6). Although
most gut microbes are not pathogenic, it is now widely appreci-
ated that they are of significant importance for the health and
performance of their vertebrate host (7, 8).
To gain a deeper understanding of the microbial populations in
the vertebrate digestive tract and their interactions with the host,
it is instructive to consider the biological principles that underlie
these partnerships in an evolutionary context. In this review, we
will attempt such an approach by first discussing the basic char-
acteristics of microbial symbiosis in the vertebrate gut before we
use findings obtained with the Gram-positive bacterium Lacto-
bacillus reuteri as a paradigm to gain insight into the ecology,
evolution, and biological role of vertebrate gut microbes.
Symbiosis with Trillions of Partners
At birth, the vertebrate digestive tract is sterile but becomes
rapidly colonized by a microbial population that, after a period of
initial fluctuations, remains remarkably stable and resilient over
time (9). This relationship can be referred to as symbiosis (from
Greek sym “with” and biosis “living”), a term that describes close
and long-term interactions between unlike organisms (10). Once
considered a rare phenomenon, microbial symbiosis is gaining
recognition as a ubiquitous feature in animal life (11). According
to the fitness effects on the host, symbiotic relationships can be
everything from beneficial to detrimental. This broad definition
of symbiosis is not universally agreed on, and some researchers
prefer to reserve the term solely for mutualistic interactions.
However, when Anton de Bary introduced the term in the mid-
nineteenth century, he characterized symbiosis as “specific cases
of parasitism and mutualism” (10).
In this article wewill follow deBary’s original definition and refer
to symbiosis as an umbrella term for mutualistic, commensal, or
parasitic relationships, including all of the interactions for which the
full spectrum of effects on the host is simply not known. Using the
term in this context is appropriate when referring to individual
members of the gut microbiota because there is currently no sci-
entific consensus on whichmicrobial taxa constitute themutualistic
and pathogenic components within this community. Although
many scientists have attempted to make such categorizations, they
remain hypothetical (and indeed difficult to prove). One has also to
consider that symbiotic relationships in the vertebrate gut exist on
a continuum between mutualism and parasitism dependent on the
host’s genetic background and environmental factors. The net ef-
fect of the gut microbiota, however, is beneficial, and of critical
importance for vertebrate biology.
Gut microbes were pivotal in the emergence of herbivorous
lifestyles in mammals and birds (12). Vertebrate genomes harbor a
very limited repertoire of glycosylhydrolases, and it is the microbes
that confer metabolic traits to extract energy from the fibrous
portion of plants, such as leaves, petioles, and stems (13). The
energy contributions through microbial metabolism, which are to
a large degree through the provision of short chain fatty acids
(SCFA), is significant in many vertebrate species, ranging from
≈70% in ruminants, 20–30% for several omnivorous animals, and
10% for humans (14). Another important attribute conferred by
the gut microbiota is the capacity to prevent enteric disease by
pathogenic microorganisms, a trait referred to as colonization re-
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sistance or microbial interference (9, 15). Vertebrate gut microbes
further contribute to epithelial barrier function, the provision
of vitamins, detoxification of xenobiotic compounds, angiogenesis,
and the development and maturation of the immune system (7).
The significant benefits provided by the gut microbiota demon-
strate that it is conceptually questionable to dismiss this symbiosis
as mere commensalism.
To Live and Let Live: The Evolution of Mutualism
In symbiotic relationships, selection pressure on the host has the
potential to lead to the improvement of beneficial traits in both
partners (11). Such mutualistic relationships are extremely well
understood in vertically transmitted symbionts of insects, such as
Buchnera aphidicola in aphids (16). These symbionts have been
stably associated with their host species over evolutionary time,
as indicated by concurrent phylogenetic trees (17–20). In most
cases, the microbes produce essential nutrients for the insects,
whereas the latter have evolved specialized cells or organs to house
them and to facilitate vertical transmission (18–20). This evolu-
tionary process often results in strong interdependencies and can
be described as coevolution in the sense that both parties have
evolved so as to sustain their mutualistic relationship (11, 16).
It is easy to envision how the crucial contributions of the gut
microbiota to vertebrate fitness (e.g., nutrient provision, pathogen
exclusion, and immune maturation) would constitute phenotypic
traits on which host selection could act (21). There are many
features of vertebrates and their microbes that give testimony for
an evolutionary alliance. Vertebrates possess specialized organs
(foreguts, hindguts, ceca, enlarged crops in herbivorous birds)
that facilitate microbial fermentation of plant materials (13).
Furthermore, an extensive gut-associated mucosal immune sys-
tem has evolved to regulate and maintain beneficial microbial
communities (22, 23). Further evidence for human evolution with
gut microbes arises from the presence of a large array of complex
oligosaccharides in breast milk. These structures have no obvious
nutritional value to the infant, but have likely emerged to support
the growth of bacteria that benefit the infant (24). In parallel, gut
bacteria have evolved elaborate systems that facilitate their own
survival but which also benefit the host. One example is the ability
of microbes to ferment complex polysaccharides to SCFA, which
are then absorbed by the host and fulfill trophic functions (24–26).
In addition, SCFA and other allelopathic compounds produced
by gut bacteria benefit the host by inhibiting pathogens (15, 27).
Finally, symbionts have evolved more specific factors, such as
the polysaccharide A (PSA) of Bacteroides fragilis, that drive the
maturation of the immune system (28).
Although vertebrate gut microbes provide clear benefits to
their hosts, the development of bacterial traits that support the
partnership poses a series of challenging evolutionary questions.
Why would selection on the host favor microbes that provide
a service rather than “cheaters” present within the community
that accept benefits but provide nothing in return (29)? Micro-
bial traits that evolve specifically to benefit the host but impose
a fitness cost to the bearer create a conflict and the potential for
“cheating” (30). In a microbial community like the gut micro-
biota, “bottom-up” selective pressures to compete with other
microbes present in the same niche would always prevent such
costly cooperative investments. However, traits that contribute to
the fitness of the microbes and incidentally benefit the host (by-
product benefits) result in a no-cost mutualism that does not
generate a conflict (30). Many beneficial traits of gut microbes
(SCFA, competition with pathogens) fall within this category.
When the host receives such automatic by-products, selection
pressure on the host can shape these traits to maximize the
benefits (31). In addition, partner-fidelity feedbacks could accrue
and promote positive selection for evolutionary events that are
advantageous to the host but neutral to the microbe’s fitness, fa-
voring cooperation without generating an opportunity for cheat-
ing. This process could be highly relevant in the evolution of
mutualism, because themajority of evolutionary changeswithin an
organism are selectively neutral (32). The host could then further
select actively, through its adaptive immune functions or the
evolution of specific attachment sites, for beneficial microbes (21).
The evolutionary process described herein would result in
a win-win situation in which the host provides the habitat for gut
microbes (which are often extremely rare in the environment)
while the microbes provide benefits such as access to fibrous diets
and prevention of enteric infections (13, 15). Unfortunately, we
have no empirical data on the evolutionary outcomes of verte-
brate symbiosis in terms of measurable fitness benefits for the
host. Research with gnotobiotic animals has provided clear evi-
dence for the significant contributions of the microbiota to colo-
nization resistance and nutrient utilization (2, 15), but we do not
know to what degree these attributes are adaptive or coincidental.
We also lack a general theory about the ecological and evolu-
tionary factors that favor mutualism in gut ecosystems. In other
symbiotic systems, vertical transmission over evolutionary time
has been shown experimentally to promote traits that enhance
partner performance (30, 33). Repeated interactions appear im-
portant for cooperation to evolve, which argues that mutualism
will be favored when the partners stay together in stable associ-
ations and align their fitness interests (29). If we also assume this
to account for the evolution of mutualism in vertebrates, then our
interpretation of symbiotic interactions would benefit from phy-
logenetic studies that provide predictions about the evolutionary
relationships of gut microbes with their hosts.
Evolutionary Strategies of Vertebrate Symbionts
The phylogenetic patterns of the human and mouse gut micro-
biota are characterized by a high level of strain and species vari-
ation but far fewer intermediate and deep lineages, and a very low
diversity at the phylum level when compared with other microbial
habitats such as soil and sea water (34). Ley et al. (34) argued that
this genetic “shallowness” and “fan-like” phylogenetic architec-
ture suggests a pattern of recent adaptive radiations, where
a small initial community that became associated with animals
gave rise to a diverse array of descendants. It is often postulated
that this process involved coevolution of individual microbial
lineages with vertebrates, which is supported by the presence of
phylotypes that are specific to particular hosts (21). However,
clear evidence for stable associations and codiversification of
microbial lineages with vertebrates has not been provided by 16S
rRNAdata. Patterns of community similarity provide evidence for
codiversification of entire gut communities with their hosts, which
suggests that there are in fact host-specific evolutionary inter-
actions between mammals and their microbiomes (12).
It is important to point out that coevolution is just one possible
mechanism by which microbes evolve with animal hosts (17), and
there is little reason to assume that there will be a universal pat-
tern of evolutionary dynamics that applies to all vertebrate gut
microbes. Many microbial lineages and species, such as Escher-
ichia coli, are found in many different vertebrates, and these
organisms could follow a promiscuous lifestyle (12, 35). It is fur-
ther likely that many gut microbes have occasionally switched
hosts. Such dynamic patterns of evolutionary transmission are
illustrated by facultative symbionts of insects, which are often
erratically distributed and resemble invasive pathogens in that
they spread through various host lineages (16). It will require
appropriate phylogenetic approaches to reveal the exact evolu-
tionary relationships between microbes and vertebrates. Because
of their slow evolution, 16S rRNA sequences have a significant
limitation in such studies. The average substitution rate of bac-
terial 16S rRNA genes has been calculated as ≈1% per 50 million
y, and the closely related species Escherichia coli and Salmonella
enterica are predicted to have separated more than 100 million y
ago (36, 37). Although such estimates have to be taken with
4646 | www.pnas.org/cgi/doi/10.1073/pnas.1000099107 Walter et al.
caution, it is likely that most of the lineages detected in contem-
porary vertebrates have diversified before they became associated
with their vertebrate hosts. Therefore, evolutionary studies of gut
symbionts will require, in many cases, more sensitive population
genetic approaches. Techniques such as multilocus sequence
analysis (MLSA) proved very valuable in studying evolution of
bacterial pathogens and environmental microbes (38–40).
The only vertebrate gut microbe that was intensively studied with
population genetic approaches is E. coli, and this body of work was
recently summarized in a review by Tenaillon et al. (35). The
population structure of this organism consists of well-supported
phylogenetic groups that have no clear association with particular
vertebrate hosts. Therefore, the data does not suggest that E. coli
lineages form stable evolutionary relationships with particular ani-
mals. Instead, E. coli seems to use dynamic and diverse adaptive
strategies that are driven by both host and environmental factors,
and it appears that the organism has evolved to occupy niches
within a broad host range and also in secondary habitats in the
environment (35).
Lactobacillus reuteri as a Model Gut Symbiont
The Gram-positive bacterium L. reuteri is an excellent model
for basic studies on ecological and evolutionary mechanisms of
a vertebrate gut symbiont. L. reuteri is found in the digestive tract
of mammals such as humans, pigs, hamsters, mice, rats, dogs,
sheep, cattle, and different birds (41). In pigs, rodents, and
chickens, L. reuteri is one of the most abundant species present in
the gut and can be detected in a large subset of animals (42–45).
In contrast, the prevalence of L. reuteri is much lower in humans,
where the species is only occasionally found (46). For example,
Molin et al. (47) reported that only 4% of the human subjects
harbored L. reuteri on the GIT mucosa. Nevertheless, the type
strain of L. reuteri, DSM 20016T, could be continuously isolated
from a human subject over several months, and the species has
been considered autochthonous to the human digestive tract (41,
48). There is some evidence that the prevalence of L. reuteri in
human fecal samples was higher in the middle of the past cen-
tury. Gerhard Reuter and Tomonari Mitsuoka, who in the 1960s
and 1970s intensively studied the Lactobacillus biota of the hu-
man digestive tract, reported that L. reuteri was then one of the
dominant lactobacilli and regularly detected (41, 48). The low
prevalence in humans in more recent studies suggests a re-
duction of the L. reuteri population size during the past 50 y.
Although we need further data to confirm such a decline, a re-
duction in prevalence within the past decades has also been
observed for other microbial lineages (35, 49). In this respect, it
is of considerable relevance that a very recent population bot-
tleneck is also supported by the clonal nature of human L. reuteri
strains (see following).
The ecological strategies of L. reuteri are fundamentally dif-
ferent in humans and animals (46). Mice, rats, pigs, and chicken
contain thick cell layers of lactobacilli that line parts of their
upper digestive tract, and L. reuteri is a large component of these
biofilms (50–52). L. reuteri adheres directly to cells of the strat-
ified squamous epithelium present at these sites (the murine
forestomach, porcine pars esophagus, and chicken crop; Fig. 1)
(53, 54). Several surface proteins of L. reuteri that are involved in
biofilm formation and the binding to epithelia, epithelial cells, or
mucus have been functionally characterized (Table 1). Proteins
such as Mub and Lsp contain LPXTG cell wall binding motifs,
are extremely large, contain multiple repeated motifs, and re-
semble adhesins of pathogenic microbes (55, 56). In contrast,
stratified squamous epithelia are absent in the human gut, and
epithelial cell layers rich in lactobacilli equivalent to those found
in the above-mentioned animals have not been described (46).
L. reuteri strains, like other lactobacilli, are fastidious and rely on
the availability of easily fermentable sugars, amino acids, vitamins,
and nucleotides. If these factors are provided, the organisms grow
very fast (duplication times of less than an hour), and L. reuteri can
use several external electron acceptors (fructose, glycerol, nitrate)
to gain additional energy and increase growth rates (57–59). The
growth requirements of L. reuteri are satisfied in the proximal di-
gestive tracts of rodents, pigs, and chickens as substrates get sup-
plied through the diet. However, easily accessible nutrients are in
low supply in the human colon due to their prior absorption in the
small intestine. The ability ofL. reuteri to use 1,2-propanediol as an
energy source (which is also a common trait in Enterobacteriaceae)
might therefore constitute an important colonization factor in the
human gut (60). The enzyme for 1,2-propanediol utilization, diol
dehydratase, is vitamin B12 dependent, and the encoding genes are
organized in the same genomic context as the vitamin B12 synthesis
operon (61). The enzyme is also involved in the utilization of
glycerol as an electron acceptor and reuterin formation (60). This
gene cluster is therefore likely to play several important roles in the
biology of L. reuteri.
Transmission from generation to generation is a key factor for
the success of a vertebrate symbiont, and it is not entirely clear to
what degree vertebrate symbionts are transmitted vertically or
horizontally. Similar to other GIT bacteria, L. reuteri may be
transferred to the newborn child or animal during birth via vaginal
transmission (62). L. reuteri has been experimentally shown to be
maternally transmitted in humans and pigs (63, 64). Interestingly,
L. reuteri is present in low numbers in milk from humans, pigs, and
dogs, and thus transmission to the next generation might be fa-
cilitated by inoculation during lactation (65–67).
Sticking Together: Evolution of L. reuteri with Its Host
To gain insight into the evolution of L. reuteri, we have recently
characterized the population genetic structure and phylogeny of
10  μm 0.5  μm 
A B
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Stratified squamous epithelium
Fig. 1. Associations of L. reuteri strain 100-23 with the for-
estomach epithelium of an ex-Lactobacillus-free mouse 7 d
after inoculation. The micrographs were produced by trans-
mission electron microscopy as described by Walter et al. (99).
(A) Biofilm formed on the stratified squamous epithelium
present in the forestomach. (B) L. reuteri cells that adhere
directly to stratified cells.
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strains isolated from six different hosts (human, mouse, rat, pig,
chicken, and turkey) from global geographic locations (68). Al-
though the 16S rRNA genes of the isolates used in the study
were >99% identical, there was considerable genetic heteroge-
neity within the L. reuteri population that could be resolved by
amplified fragment length polymorphism and MLSA. Most im-
portantly, both techniques detected the presence of phylogenetic
groups with a high reflection of host origin but not geographic
location. Figure 2 shows the reconstruction of genealogies of
the L. reuteri population based on MLSA data using the Clonal-
Frame software. The phylogeny that is now available for L. reuteri
allows a prediction of the evolutionary and ecological strategies of
this species. The presence of lineages that track with host origin
indicates a stable association of L. reuteri lineages with particular
vertebrates over a long evolutionary time-span and host-driven
diversification. However, the population structure also indicates
that evolution was not specific to the host genus, because isolates
from rodents (mice and rats) and poultry (chickens and turkeys)
form joint clades. This suggests that L. reuteri lineages evolved
with groups of related vertebrates and occasional horizontal
transfer between these hosts (68).
The population genetic analysis indicates that L. reuteri employs
amarkedly different lifestyle and adaptive strategy than commensal
E. coli. Significant secondary habitats outside the hosts have not
been identified forL. reuteri, and the high host specificity of genetic
clusters indicates that this species is composed of subpopulations
that have become host adapted. Host specialization is indeed
reflected by the phenotypic characteristics of strains. Several ex-
periments in animals showed that indigenous strains of L. reuteri
outperform exogenous strains when competing in the gastrointes-
tinal tract (63, 68–71). Furthermore, the ability of L. reuteri strains
to adhere to epithelia and epithelial cells in the proximal gut is to
a large degree host-specific (53, 54, 72). Strains originating from the
forestomach of rodents adhere to epithelial cells of mice and rats,
but do not adhere to crop epithelial cells. Conversely, isolates from
poultry do not adhere to epithelial cells from the rodent forest-
omach or the pars oesophagea of pigs.
To gain additional insight into the phenotypic diversification
within L. reuteri, we have investigated 32 L. reuteri strains isolated
from different hosts for their ability to produce the enzyme urease
and the antimicrobial compound reuterin. These factors were
chosen as they are likely to play an important role in the gut,
potentially contributing to acid resistance (urease) and reuterin
formation/propanediol fermentation (58, 73, 74). Our analyses
revealed that all rodent strains (n = 9) produced urease and
harbored the ureC gene (encoding the urease alpha subunit),
whereas only one of the 23 strains isolated from other hosts was
positive for these traits (Fig. 2A). In contrast, only one of the
rodent strains produced reuterin and possesed the pduC gene
(encoding a subunit of diol/glycerol dehydratase, the first enzyme
in the propanediol fermentation/reuterin formation pathway),
whereas all human and poultry strains possessed these traits. The
phylogenetic distribution of these phenotypic factors indicates
that they evolved to access specialized niches in respective hosts.
Table 1. Proteins of L. reuteri involved in adherence to epithelia and/or biofilm formation
Protein Full name Strain(s) Origin
Putative function in the
gastrointestinal tract Refs.
CnBP/MapA Collagen-binding protein DSM20016T, RC-14, 104R Human, hamster, pig Binding to epithelial cells or mucus 100–102
Mub Mucus-binding protein 1063 Pig Binding of mucos and/or IgA 55, 103
Lsp Large surface protein 100-23 Rat Adherence to forestomach epithelium 56
GtfA/ Inu Glycosyl-transferases L. reuteri TMW1.106 Food fermentation Cell aggregation, biofilm formation 104
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Fig. 2. Phylogenetic and genomic analysis of L. reuteri isolates originating from different vertebrate hosts. (A) Genealogy of 116 L. reuteri strains as inferred
from MLSA sequences using the ClonalFrame software as described by Oh et al. (68). The branches in the tree are color coded by host origin, and cohesive
subpopulations are labeled. The human cluster II is enlarged, and the four sequence types (STs, strains with seven identical housekeeping genes) represented
in this cluster are indicated. Strains that produce reuterin and posses the pduC gene (large subunit of glycerol/diol dehydratase) are marked by closed black
circles; strains that do not produce reuterin or possess the pduC gene are marked with open black circles. Strains that produce urease and posses the ureC
(urease alfa subunit) are marked with closed red circles; strains that do not produce urease or the ureC gene are labeled with open red circles. (B) Human
isolates of the L. reuteri cluster II form one clonal complex (CC). Allelic profiles were analyzed by eBurst, and CCs were defined as sets of related strains sharing
identical alleles at five of the seven MLSA loci with at least one other member of the group. The figure shows the clonal grouping among the human L. reuteri
strains of cluster II, which is comprised of four STs. The black circle in the middle indicates the putative founder (ST47). (C) Visualization of SNPs in the
genomes of the human L. reuteri strains JCM 1112T (DSM 20016T), ATCC PTA 4659, ATCC PTA 5289, and ATCC 6475. SNPs with red markings are found solely in
ATCC PTA 4659, SNPs with blue markings are found solely in ATCC PTA 5289, and SNPs with black markings are found in ATCC 4659, 5289, and 6475.
Nonsynonymous SNPs are represented with thick markings and synonymous SNPs with thin markings.
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The population structure and phenotypic characteristics of the
isolates described herein identify the host environment as the
major factor in the evolution of L. reuteri. Although we do not
yet know the precise ecological forces that drive diversification,
the population genetic structure indicates marked differences
between hosts. The genetic heterogeneity is much higher in the
two rodent lineages when compared with other clusters, and
recombination played an important role in generating this di-
versity (68). In contrast, genetic variation and the impact of re-
combination in the clusters from pigs, poultry, and humans are
much lower. The cluster with the lowest genetic homogeneity is
the human cluster II. Most human isolates in this subpopulation
fall into one single clonal complex (CC), meaning that they share
at least five of the seven MLSA loci (Fig. 2B). To gain additional
insight into the genetic diversity within the human cluster II, we
have sequenced the genomes of three strains that belong to the
most common sequence type (ST4) by Illumina sequencing and
compared the sequences to the genome of L. reuteri DSM20016T
(JCM 1112T), which is a member of ST4. This analysis revealed
a total of only nine single-nucleotide polymorphisms (SNPs) in
the four genomes (Fig. 2C and Table S1). This is remarkable, as
these strains have been isolated in Germany, Finland, and Japan
over a time span of almost 40 y. This data indicates a recent
selective sweep or a population bottleneck in the human L.
reuteri population. We do not know if this bottleneck was caused
by a recent change in the human environment, but such an event
would explain the decreased prevalence of L. reuteri in humans.
Making an Impact: Beneficial Effects Conferred by L. reuteri
The phylogenetic patterns detected for L. reuteri indicate a stable
evolutionary relationship with the host, which, in theory, has the
potential for the development of mutualistic interactions (21, 29,
30). As described previously, we lack empirical data that would
provide direct evidence for such a process. Nevertheless, the
beneficial attributes of L. reuteri have been researched inten-
sively during the past three decades because of the common use
of different strains as probiotics (Table 2). Although these
experiments were not designed to study symbiotic interactions
per se, they still suggest beneficial attributes of L. reuteri in both
humans and animals.
The effects of L. reuteri on the host were studied in animal
models using rodents, turkeys, chickens, and pigs. For example,
intestinal resistance to the eukaryotic pathogen Cryptosporidium
parvum was increased by L. reuteri in a murine model of acquired
immunodeficiency syndrome (75). In addition, Casas and
Dobrogosz (63) have found that administration of L. reuteri re-
duced mortality in chickens and turkeys upon infection with Sal-
monella. The mechanisms that underlie this protection have not
been clearly identified, but might include an increase in compet-
itive exclusion. Various L. reuteri strains produce an array of an-
timicrobial compounds that inhibit pathogens in vitro (76, 77).
The best characterized of those, reuterin, is a mixture of different
forms of beta-hydroxypropionaldehyde (3-HPA) that have bac-
tericidal and bacteriostatic activity against a wide range of bac-
terial pathogens (77). Although many bacteria contain the
pathway to reduce glycerol, L. reuteri is unique as it secretes high
levels of reuterin. The role of reuterin in competitive exclusion
has not been addressed directly, but it has been shown to decrease
E. coli population in an in vitro model of colonic fermentation
(78). In addition, L. reuteri strains are much more resistant to
reuterin than most other bacteria, indicating that the antimicro-
bial activity of reuterin is of ecological and evolutionary signifi-
cance (79).
Arguably the most intriguing feature of L. reuteri and a likely
underpinning of its probiotic effect is the ability to modulate the
host’s immune system. Empirical evidence for an immunoregula-
tory effect was achieved in several experimental models of colitis,
where L. reuteri was highly efficient in reducing inflammation (70,
71, 80–82). Immunomodulation has also been shown in humans,
where L. reuteri ATCC 55730 has been shown to temporarily col-
onize the stomach and small intestine of healthy subjects and in-
crease CD4+ T lymphocytes in the ileum (83). The physiological
implications of these immune effects are not yet established in
humans, but immunemodulationmight contribute to the reduction
in the duration and severity of diarrhea and the prevention of
sensitization and IgE-associated eczema in children (84–87).
Several trials have shown that L. reuteri does confer health
benefits in humans. In a double-blind, placebo-controlled, ran-
domized trial, L. reuteri ATCC 55730 was shown to improve the
health of infants in a daycare setting (88). Children receiving
L. reuteri supplementation had a reduced number of sick days,
antibiotic prescriptions, diarrheal episodes, and duration of di-
arrhea. L. reuteri has also been shown to improve symptoms of
infant colic (89). Colic is a poorly understood syndrome in which
Table 2. Beneficial attributes of L. reuteri studied in human and animal trials and with cell cultures
Function Observation Refs.
Humans
Prevention of diarrhea Reduced duration and severity of diarrhea caused by
rotavirus in children; reduced incidence of diarrhea in infants
86–88
Reduction of infant colic Reduced colicky symptoms in 95% of infants;
improved gastric emptying and reduced crying time
in premature infants
89, 90
Reduction of IgE-associated
eczema and sensitization
Reduction of IgE associated eczema in 2-y-olds;
reduced levels of TGF-B2
84, 85
Immune stimulation Short-term survival of L. reuteri in the stomach and
small intestine. Stimulation of CD4 lymphocytes
83
Animals
Immune stimulations Transient increase in proinflammtory cytokines and
chemokines in the intestinal tract.
97
Immune regulation Increased levels of regulatory T cells upon colonization
of Lactobacillus-free free mice with L. reuteri
96
Prevention of experimental colitis Reduced levels in animal models of colitis 70, 71, 80–82
Immune cells
Modulation of immune
reactions in cultured macrophages,
dendritic cells, and T cells
Reduction in TNF-α production in activated macrophages;
reduced production of proinflammatory cytokines in
dendritic cells, induction of regulatory T cells
53, 81, 93, 94,
96, 105
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infants, from just after birth to 6 mo, have uncontrollable crying
spells that last for at least 3 h at a time. L. reuteri was compared
with simethicone treatment for efficacy in treating colic in
a prospective controlled trial. After 28 d of treatment with L.
reuteri 95% of infants were deemed responders and found to
have significantly reduced their daily crying times, compared with
only 7% of infants receiving simethicone. The mechanism by
which L. reuteri reduces colic symptoms is not yet understood but
may be linked to stimulation of gastric emptying (90).
L. reuteri Contributes to Tolerance in the Gut
Recently, Edwards (91) proposed an important role for tolerance
strategies for the evolution, maintenance, and breakdown of
mutualism in symbiotic relationships. In the vertebrate gut, the
establishment of tolerance to the microbes is a key requirement
for peaceful coexistence (7). Strict compartmentalization by con-
fining symbiotic bacteria to the gut lumen is essential, but signals
from the microbiota are also involved by influencing the differ-
entiation of T cells and the induction of regulatory T cells (Tregs)
that suppress excessive immune responses. The significance of
immune homeostasis in the gut becomes evident in inflammatory
bowel diseases (92).
Recent studies revealed that L. reuteri might play a key role in
the induction of tolerance in the vertebrate gut (a summary of
the immune effects is provided in Fig. 3). Christensen et al. (93)
showed that L. reuteri had the ability to inhibit induction of
proinflammatory cytokines interleukin (IL)-12, IL-6, and TNF-α
in murine dendritic cells (DCs). The priming of DCs by L. reuteri,
which was initiated by the binding of C-type lectin DC-specific
intercellular adhesion molecule 3-grabbing nonintegrin (DC-
SIGN), resulted in an induction of regulatory T cells in vitro
(94). A similar down-regulation of proinflammatory cytokines
(e.g., TNF-α) by L. reuteri was also observed with macrophages,
lipopolysaccharide-activated monocytes, and primary monocyte-
derived macrophages from children with Crohn’s disease (81,
95). The bacterial molecule(s) responsible for down-regulating
TNF-α in antigen-presenting cells have not been identified to
date but appear to function by inhibiting the activation of c-Jun
and AP-1 (95).
The physiological relevance of the immune effects of L. reuteri
was recently demonstrated in vivo using Lactobacillus-free (LF)
mice (96, 97). In these animals, administration of L. reuteri resulted
in a transient activation of proinflammatory cytokines and che-
mokines produced by intestinal epithelial cells in the jejunum and
ileum (97). However, the inflammatory response was transient and
proinflammatory cytokine levels completely returned to normal
after 21 d, although high numbers of lactobacilli continued to be
present in the gut. This process could be explained by elevated
levels of IL-10, IL-2, and TGF-β in supernatants from immune cells
recovered from the mice, as well as increased levels of Foxp3-
positive regulatory T cells (96). The induction of immune tolerance
in LF-mice by L. reuteri is a remarkable finding, as these mice have
a complex microbiota that is functionally equivalent to that of
conventional mice (98). It suggests that L. reuteri contributes to the
immune regulation in the gut by modulating antigen-presenting
cells toward favoring tolerance. The ability of L. reuteri to prevent
experimental colitis in animal models indicates that the immuno-
regulatory effects of this organism can have a significant benefit for
the host (70, 71, 80–82).
Conclusions and Perspective
Researchers have just begun to unravel the complex features of
microbial symbiosis in vertebrates, and research on the evolution
of gut microbes is clearly in its infancy. Studies on the bacterium
L. reuteri have provided unique insight into the evolutionary
mechanisms of a gut microbe that maintains a close symbiotic
relationship with its vertebrate host. Despite the inevitable dis-
semination through feces,L. reuteri lineages share an evolutionary
history with particular vertebrate animals and became host
adapted. This evolutionary strategy is in striking contrast to that of
commensalE. coli, which have a broad host range and followmore
diverse adaptive strategies (35). Although we lack a general the-
ory about the consequences of such distinct evolutionary patterns
in vertebrate gut symbionts, it is intriguing that the phenotypes of
L. reuteri and E. coli in terms of their impact on the host are in
accordance with both theoretical considerations and observations
in other symbiotic systems (29, 30, 33). Specifically, the beneficial
attributes of L. reuterimight be a direct consequence of its shared
evolutionary fate (and potentially coevolution) with groups of
vertebrate hosts. In contrast, the dynamic relationship of E. coli
with vertebrates might account for the emergence of the well-
known human pathogens within this species, which contain viru-
lence factors that may have evolved coincidentally because of
their role as colonization factors in other hosts (35). If analogous
principles do apply to gut microbes in general, we could use evo-
lutionary studies to better interpret their symbiotic interactions
within the vertebrate gut microbiota.
Breakthroughs in our understanding of the roles of microbes in
the vertebrate digestive tract and the biological principles that
apply are likely to arise from studies that are informed by eco-
logical and evolutionary theory. This will require integrative
studies spanning all scales, from molecules, individual microbes,
microbial communities, and populations of vertebrate hosts, to
answer the open questions. What are the evolutionary strategies
of members of the gut microbiota other than L. reuteri andE. coli?
Are there host-specific reciprocal evolutionary interactions be-
tween specific microbes and their vertebrate hosts that could be
described as coevolution? What effect does selection pressure
have on the host in terms of the evolution of the gut microbiome?
Are symbiotic interactions and beneficial effects of microbes host-
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Fig. 3. Effects of L. reuteri on immune cells that contribute to
tolerance in the gut. L. reuteri has been shown to suppress the
production of proinflammatory cytokines such as TNF-α and
IL-12 in macrophages, monocytes, and dendritic cells. The
modulation of dendritic cells by L. reuteri has been shown to be
mediated through DC-SIGN and promote development of
regulatory T cells producing high amounts of IL-10 and TGF-β.
This suppression of immune responses is likely to underlie the
ability of L. reuteri to reduce intestinal inflammation in several
murine colitis models. Please see text for details and references.
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specific? How do environmental factors affect both evolution and
functionality of the gut microbiota? It is important to realize that
the study of symbiotic interactions in humans might already be
hampered, as features of modern lifestyle are almost certain to
have introduced bottlenecks to symbiont transmission (49). Re-
search using animal models is therefore especially important. The
elegant approaches that have been used to study microbial sym-
biosis of invertebrates can clearly serve as a paradigm for similar
research in vertebrates (16–19).
The phylogenetic and phenotypic characterization of L. reuteri
is supportive of the notion that some gut microbes form an in-
trinsic symbiotic relationship with vertebrates that is significant
for health. A disruption of these ancient partnerships through
modern lifestyle could have contributed to the recent increase in
diseases in westernized societies. If there is indeed a decrease of
ancestral microbial lineages that is linked to disease, as suggested
by Blaser and Falkow (49), such microbes could be restored to
provide the same beneficial functions that they have evolved as
members of the microbiome. However, such beneficial lineages
would have to be identified first to reach a scientific consensus on
what composes a healthy gut microbiota, and it is naïve to think
that we can modulate ancient symbiotic relationships and gen-
erate a benefit without an understanding of their evolution, the
ecological forces that shape them, and how they function (21).
Therefore it is highly unfortunate that most of the probiotic and
prebiotic strategies that have been developed to date are not
based on ecological or evolutionary criteria. In the future, se-
lection of probiotic strains and prebiotic targets could be based
on criteria such as their evolutionary relationships with the host.
It is a logical working hypothesis that symbionts that share an
evolutionary fate with their host are more likely to possess adap-
tive traits that provide benefits.
Materials and Methods
Strains were screened for the production of urease and reuterin and the
presence of the pduC and ureC genes by standard phenotypic tests and
PCR. The genome sequences of L. reuteri strains ATCC PTA 4659 (previously
MM2-3, isolated in Finland in 1997), 5289 (FJ1, isolated in Japan, around
2002), and 6475 (MM4-1a, isolated in Finland in 1997) were determined by
Illumina sequencing of genomic DNA, and the sequences were subjected
to SNP analysis. Detailed methods for the procedures are provided in SI
Materials and Methods.
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SI Materials and Methods
Determination of Urease Activity and Reuterin Production. Urease
activity was tested by suspending the bacteria from a 10-mL
overnight culture (MRS broth; Oxoid) in 10 mL sterile filtered 2%
urea solution.ThepHwasmeasuredat thebeginningandafter16h,
and an increase of more than two pH units indicated production
of urease. To detect reuterin production, the bacteria were grown
for 48 h on MRS agar plates (inoculated as streaks) in anaerobic
atmosphere. The plates were then overlaid with 500 mM glycerol
agar (1% agar) and incubated at 37 °C for 30 min. Reuterin was
detected by the addition of 5 mL 2,4-dinitrophenylhydrazine
(0.1% in 2 M HCl). After 3 min incubation, the solution was
poured off and 5 mL 5 M KOH was added. Red zones around the
bacterial streaks demonstrate the presence of reuterin.
Detection of ureC and pduC. The genes encoding urease alpha
subunit (ureC) and the large subunit of the glycerol dehydratase
(pduC) were detected by PCR analyses. The bacteria were culti-
vated on anMRS agar (Oxoid) plate and grown for 16 h at 37 °C in
anaerobic atmosphere. With a sterile plastic loop, 1 μL bacterial
cells was collected and suspended in 100 μL sterile water. The
PCRs were performed using PuReTaq Ready-To-Go PCR Beads
(GE Healthcare) and primers (0.4 μM of each) for detecting ureC,
ureCF (5′-GAAAGTCTTTTTGGTGGTGG-3′), and ureCR (5′-A-
ACGTCGTCAGGAATCTTAG-3′); and pduC, pduCF (5′-CCT-
GAAGTAAAYCGCATCTT-3′), and pduCR (5′-GAAACYAT-
TTCAGTTTATGG-3′). Bacterial suspension (0.5 μL) was added to
the PCR mix (in total 25 μL), and the PCR was performed by
running the program 95 °C, 5min; 30× (95 °C, 30 s; 53 °C, 30 s; 72 °C,
30 s); 72°, 10 min. The PCR products were separated and visualized
by using standard agarose gel electrophoresis.
Illumina Sequencing of L. reuteri Genomes. L. reuteri strains used in
this study were ATCC PTA 4659 (previously MM2-3, isolated in
Finland in 1997), 5289 (FJ1, isolated in Japan, around 2002), and
6475 (MM4-1a, isolated in Finland in 1997), grown in MRS
media (Difco) and genomic DNA prepared by using the Qiagen
Genomic-Tip System. DNA was fragmented by 20 min sonica-
tion (130 W) to obtain an average fragment size of 500 bp, then
further purified and concentrated with QIAquick PCR Purifi-
cation Spin Columns (Qiagen). Treatment to remove 3′ over-
hangs and fill in 5′ overhangs resulted in blunt-ended genomic
fragments. An adenine residue was added by terminal trans-
ferase to the 3′ end, and the resulting fragments were ligated to
Solexa adapters. The products were separated by agarose gel
electrophoresis, and the band between 150 and 200 bp was ex-
cised from the gel. The DNA fragments were extracted from the
agarose slice using a QIAquick Gel Extraction Kit (Qiagen).
Adapter-modified DNA fragments were enriched by an 18-cycle
PCR using Solexa universal adapter primers. The DNA fragment
library was quantitated, then diluted to a 10-nM working stock
for cluster generation. Adapter-ligated fragments (2 nM) were
denatured in 0.1 M NaOH for 5 min, then further diluted to
a final 9 pM concentration in 1 mL of prechilled hybridization
buffer, and introduced onto the Solexa flow cell using the Cluster
Station. Following isothermal amplification, clusters were made
single-stranded by 0.1 M NaOH denaturation, metered across
the flow cell by the Solexa Cluster Station. A sequencing primer
complementary to one Solexa adapter was added to prime the
single strands of each cluster. Once hybridized and with excess
primer removed by a wash, the flow cell was ready for se-
quencing. The Solexa Genome Analyzer II was programmed to
provide up to 36 sequential flows of fluorescently labeled, 3′-OH
blocked nucleotides and polymerase to the surface of the flow
cell, thus producing a fixed 36-bp read length. After each base
incorporation step, the flow cell surface was washed to remove
reactants and then imaged by microscope objective. The ex-
periments collected 300 tiled images (“tiles”) per flow cell lane,
each containing on average 30,000 clusters.
SNP Analysis. The three lanes’ sequencing results were mapped
onto the reference genome L. reuteri JCM 1112T (GenBank
accession no AP007281) separately. The mapping software Maq
version 0.6.6 (http://maq.sourceforge.net/maq-man.shtml) was
used to perform the mapping (default parameters). SNPs were
identified and validated by the MAQ software, and classified into
coding SNP and intergenetic SNPs. Coding SNPs were identified
as synonymous and nonsynonymous. The SNPs were finally veri-
fied by PCR amplification of the surrounding region, followed by
Sanger sequence determination.
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Table S1. Single-nucleotide polymorphisms (SNPs) in human L. reuteri strains compared with L. reuteri JCM 1112T (GenBank AP007281)
SNP Strain
Position (in genome
JCM 1112T) Coding
Gene in genome
JCM 1112T Annotation Nonsynonymous
GenBank
accession no.
1 4659 271 391 + LAR_0226 Conserved hypothetical protein − GU563996
2 4659 453 538 + LAR_0387 Chloride channel protein + GU563997
3 4659 529 228 + LAR_0456 ATP synthase gamma subunit + GU563998
4
4659,
5289,
6475 567 368 + LAR_0489 Thiamine biosynthesis protein ThiI − GU563999
5 4659 599 338 + LAR_0512 DNA mismatch repair protein HexB + GU564000
6
4659,
5289,
6475 968 088 + LAR_0849 Two-component sensor histidine kinase + GU564001
7 5289 1 239 672 + ORF between
LAR_1080
and 1081
Conserved hypothetical protein + GU564002
8
4659,
5289,
6475 1 358 460 + LAR_1203 Penicillin-binding protein 2A − GU564003
9 5289 1 793 677–8 + LAR_1579 Multidrug ABC transporter ATP-binding
and permease components
+ GU564004
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